Northport 2016 BWH/Harvard
Crohn’s & Colitis Study Underway
~ Still Recruiting Participants ~
Dr. Josh Korzenik, The Director of the Crohn’s and Colitis Center at Brigham and Women’s Hospital (BWH), one of the leading IBD researchers in the country, and his team have begun their second study of the health cluster of ulcerative colitis and Crohn’s disease diagnosed in Northport residents. Their 2011 study concluded diagnosed cases of ulcerative colitis or Crohn’s disease in the community was 10 to 15 times higher than national standards. This was one of the largest health clusters of these illnesses Dr. Korzenik has ever seen.
The current study is a more in-depth epidemiological case-control study. The focus is in finding a possible correlation of chronic exposure to specific heavy metals and ulcerative colitis and Crohn’s disease.
The case-control study includes participants who have been diagnosed with either Crohn’s or colitis as well as participants who have not been affected. In March I asked for volunteers for this new study. The response I received was overwhelming. I provided the full list to Dr. Korzenick, however if you volunteered and have still not heard from them please call or e-mail them at: IBDresearch@bwh.harvard.edu or 617-732-9173.
It is not too late to volunteer if you haven’t. They are still recruiting participants.
The scope of this study, and the study itself, has the very likely possibility of providing groundbreaking information the scientific community is greatly lacking.
Thank you to the many past and present Northport residents who have volunteered to participate in this study.
We cannot change the past or the damage Teck’s pollution has caused, and continues to cause, to countless Northport residents. However, by participating in studies like this invaluable information on the routes and duration of exposure to specific environmental toxins have in triggering or causing these rare diseases. This could help accomplish prevention, regulatory changes, and better treatment options and cures for Crohn’s disease, ulcerative colitis, and possibly many other autoimmune diseases.
– Jamie Paparich